Compare Borosil Scienti. with Similar Stocks
Dashboard
Poor Management Efficiency with a low ROE of 4.53%
- The company has been able to generate a Return on Equity (avg) of 4.53% signifying low profitability per unit of shareholders funds
Poor long term growth as Net Sales has grown by an annual rate of 9.80% and Operating profit at 2.86% over the last 5 years
With ROE of 4.5, it has a Expensive valuation with a 2.2 Price to Book Value
Despite the size of the company, domestic mutual funds hold only 0.04% of the company
Below par performance in long term as well as near term
Stock DNA
Industrial Products
INR 923 Cr (Micro Cap)
37.00
44
0.00%
-0.27
4.53%
2.29
Total Returns (Price + Dividend) 
Borosil Scienti. for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

Borosil Scientific Ltd Technical Momentum Shifts Amid Bearish Outlook
Borosil Scientific Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a transition from mildly bearish to bearish trends. Despite a modest intraday price gain, the stock’s broader technical landscape suggests caution for investors amid weakening momentum and persistent downward pressures.
Read full news article
Borosil Scientific Ltd is Rated Sell
Borosil Scientific Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 11 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Borosil Scientific Ltd Technical Analysis: Momentum Shift Amid Bearish Sentiment
Borosil Scientific Ltd, a micro-cap player in the industrial products sector, has experienced a subtle shift in its technical momentum, moving from a strongly bearish stance to a mildly bearish one. Despite this slight improvement, the stock continues to face downward pressure, reflected in its recent price action and technical indicators.
Read full news article Announcements 
Closure of Trading Window
26-Mar-2026 | Source : BSEClosure of Trading Window
Announcement under Regulation 30 (LODR)-Investor Presentation
13-Feb-2026 | Source : BSEInvestor presentation for unaudited financial results for quarter and nine months ended December 31 2025
Financial Results For The Quarter And Nine Months Ended December 31 2025
11-Feb-2026 | Source : BSEFinancial Results for the quarter and nine months ended December 31 2025
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Promoters
None
Held by 1 Schemes (0.01%)
Held by 18 FIIs (0.07%)
Kiran Kheruka (25.52%)
Borosil Scientific Limited Unclaimed Securities Suspense Escrow Account (2.2%)
23.06%
Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ
QoQ Growth in quarter ended Dec 2025 is 13.47% vs 11.38% in Sep 2025
QoQ Growth in quarter ended Dec 2025 is 200.35% vs 169.47% in Sep 2025
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is -1.90% vs 15.21% in Sep 2024
Growth in half year ended Sep 2025 is -109.18% vs 62.32% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is 5.16% vs 10.41% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -59.13% vs 27.14% in Dec 2024
Annual Results Snapshot (Standalone) - Mar'25
YoY Growth in year ended Mar 2025 is 10.51% vs 9.00% in Mar 2024
YoY Growth in year ended Mar 2025 is 11.32% vs 3.25% in Mar 2024






